Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
暂无分享，去创建一个
Rosalyn W. Sayaman | E. Petricoin | L. Esserman | L. Pusztai | Minetta C. Liu | D. Yee | C. Yau | W. Symmans | H. Rugo | C. Isaacs | A. DeMichele | D. Wolf | M. J. Magbanua | J. Wulfkuhle | L. Brown-Swigart | J. Matthews | P. Pohlmann | J. Perlmutter | N. Hylton | Jean-Philippe Coppé | G. Hirst | A. Basu | L. Sit | P. Lee | A. Delson | S. Asare | R. Lu | L. J. van ‘t Veer | I. Gallagher | Zelos Zhu | Nick O'Grady | J. Braun | D. Berry | L. J. van ’t Veer | Isela Gallagher | Nick O’Grady | Amy L Delson